We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Justice Department Investigating GSK's Nominal Pricing Arrangements
Justice Department Investigating GSK's Nominal Pricing Arrangements
March 9, 2005
The Justice Department is investigating GlaxoSmithKline’s (GSK) use of nominal pricing arrangements to determine whether the pricing strategy violates Medicaid price-reporting rules.